Composition
- Active ingredients
- PHENTOLAMINE MESYLATE EQ 0.75% BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA217064.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ryzumvi
- Active substance
- phentolamine mesylate
- Route
- Eye
- Dosage form
- Solution
- Applicant
- Famygen Life Sci
- Status
- Prescription
- FDA approval
- 25 Sept 2023
- Application
- NDA217064-001